As ER stress is involved in many retinopathies, including diabetic retinopathy, glaucoma, and AMD, our study warrants further investigation of the ER stress/tauopathy pathways in these diseases and evaluation of whether boosting GRP78 expression and blocking tau oligomers are also beneficial in these diseases. The gene discussed is MAPT; the disease is retinal disorder.